Mesoblast Ltd SEC filings MEOBF
Mesoblast Ltd has 598 filings in SEC EDGAR's recent list, going back to Nov 8, 2005. Its latest annual report, Form 20-F, was filed on Aug 27, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jan 14, 2026 | — |
| CORRESP | Letter to the SEC | Jan 12, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2026 | — |
| EFFECT | Filing | Feb 12, 2025 | — |
| CORRESP | Letter to the SEC | Feb 10, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2025 | — |
| EFFECT | Filing | Dec 27, 2024 | — |
| CORRESP | Letter to the SEC | Dec 23, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2024 | — |
| EFFECT | Filing | Apr 24, 2024 | — |
| CORRESP | Letter to the SEC | Apr 22, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2024 | — |
| EFFECT | Filing | May 26, 2023 | — |
| UPLOAD | Letter from the SEC | May 24, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| EFFECT | Filing | Apr 3, 2023 | — |
| CORRESP | Letter to the SEC | Mar 30, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2023 | — |
| EFFECT | Filing | Dec 30, 2022 | — |
| CORRESP | Letter to the SEC | Dec 28, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2022 | — |
| EFFECT | Filing | Dec 22, 2022 | — |
| EFFECT | Filing | Sep 12, 2022 | — |
| CORRESP | Letter to the SEC | Sep 8, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2022 | — |
| D | Filing | May 26, 2020 | — |
| CT ORDER | Filing | Oct 4, 2018 | — |
| EFFECT | Filing | Jul 21, 2017 | — |
| CORRESP | Letter to the SEC | Jul 20, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2017 | — |
| CT ORDER | Filing | Dec 22, 2015 | — |
| EFFECT | Filing | Nov 12, 2015 | — |
| CERTNAS | Auto-generated paper document | Nov 10, 2015 | — |
| CORRESP | Letter to the SEC | Nov 9, 2015 | — |
| 8-A12B | Form 8-a12b | Nov 9, 2015 | — |
| CORRESP | Letter to the SEC | Nov 6, 2015 | — |
| EFFECT | Filing | Oct 19, 2015 | — |
| DRS/A | Filing | Oct 7, 2015 | — |
| DRSLTR | Filing | Sep 21, 2015 | — |
| DRS/A | Filing | Sep 21, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2015 | — |
| DRS | Filing | Jun 26, 2015 | — |
| DRS/A | Filing | Mar 27, 2015 | — |
| DRS/A | Filing | Feb 24, 2015 | — |
| DRS/A | Filing | Jan 9, 2015 | — |
| DRS/A | Filing | Dec 16, 2014 | — |
| DRS/A | Filing | Dec 10, 2014 | — |
| DRS | Filing | Nov 10, 2014 | — |
| SUPPL | Auto-generated paper document | Aug 4, 2008 | — |
| SUPPL | Auto-generated paper document | Jun 2, 2008 | — |
| SUPPL | Auto-generated paper document | Mar 13, 2008 | — |
| SUPPL | Auto-generated paper document | Jan 15, 2008 | — |
| SUPPL | Auto-generated paper document | Dec 3, 2007 | — |
| SUPPL | Auto-generated paper document | Jul 26, 2007 | — |
| SUPPL | Auto-generated paper document | May 29, 2007 | — |
| SUPPL | Auto-generated paper document | Mar 23, 2007 | — |
| SUPPL | Auto-generated paper document | Feb 8, 2007 | — |
| SUPPL | Auto-generated paper document | Jan 16, 2007 | — |
| SUPPL | Auto-generated paper document | Dec 13, 2006 | — |
| SUPPL | Auto-generated paper document | Nov 6, 2006 | — |
| SUPPL | Auto-generated paper document | Oct 16, 2006 | — |
| SUPPL | Auto-generated paper document | Sep 12, 2006 | — |
| SUPPL | Auto-generated paper document | Aug 2, 2006 | — |
| SUPPL | Auto-generated paper document | Jun 27, 2006 | — |
| SUPPL | Auto-generated paper document | May 30, 2006 | — |
| SUPPL | Auto-generated paper document | May 2, 2006 | — |
| SUPPL | Auto-generated paper document | Apr 4, 2006 | — |
| SUPPL | Auto-generated paper document | Feb 22, 2006 | — |
| SUPPL | Auto-generated paper document | Jan 26, 2006 | — |
| SUPPL | Auto-generated paper document | Nov 8, 2005 | — |
| 12G3-2B | Auto-generated paper document | Nov 8, 2005 | — |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MESO (Nasdaq), MEOBF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Melbourne, Victoria, Australia
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1345099
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.